News

Researchers Identify Genes That Delay Alzheimer’s Disease

Researchers have discovered a network of nine genes that play a key role in Alzheimer’s disease onset. The study entitled “APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease” was published in the journal Molecular Psychiatry. Alzheimer’s disease age of onset varies greatly between individuals, a phenotype…

Exercise Boosts the Brain In Alzheimer’s Patients, According to Research

It is widely accepted that exercise is good for your health, but can it even increase brain cells? That is the conclusion from several new reports published in the first issue of the journal Brain Plasticity. Overall, the publications presented several pieces of compelling evidence revealing that exercise benefits the brain,…

Alzheimer’s Study Finds a Target in a Stress Neurotransmitter

University of California researchers recently showed that the targeting of a neurotransmitter involved in stress responses significantly reduced cellular and tissue damage while preventing the onset of cognitive impairment in a transgenic mice model of Alzheimer’s disease. The study, entitled “Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology…

Alzheimer’s-Linked Protein Seems to Respond to Exercise

Everyone knows that exercise is good for you, both physically and mentally. Now, a new study suggests that physical activity may not only boost brainpower, it might even prevent Alzheimer’s disease. Researchers from St. Louis, Missouri, studied mice with an experimental form of Alzheimer’s disease and found that those mice doing the…

Neuroinflammation in Alzheimer’s Is Again a Therapy Target

Neuroinflammation in the central nervous system is a known key event in Alzheimer’s pathogenesis and has long been proposed as a therapeutic target, but studies conducted in the early 2000s of potential anti-inflammatory treatments didn’t produce the hoped for outcomes. Now a renewed interest is emerging in Alzheimer’s disease (AD) treatments targeting neuroinflammation, still a…

Alzheimer Studies Faulted for Waste, Ineffective Outcomes

Sometimes more is not necessarily better. This may especially be true of Alzheimer’s disease clinical studies, too many of which have been tried and failed, leading top scientists to question their design and execution. Better planning in the application of more promising approaches might make more sense — and improve a…